Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine used for treating influenza, upper respiratory infection and viral pneumonia

A technology for viral pneumonia and upper respiratory tract, applied in the field of medicine, can solve the problems of improper treatment, long relief time, easy to cause bronchial, pneumonia, tuberculosis and other problems, and achieve the effect of reducing the amount of use

Pending Publication Date: 2016-05-04
SHANDONG ZHONGHAI PHARMA CO LTD
View PDF10 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] (1) After administration, the body temperature cannot be controlled within a short period of time, and the body temperature changes greatly;
[0012] (2) The antipyretic effect on influenza patients is not obvious, and the antipyretic time is long after administration;
[0013] (3) It takes a long time to relieve cough, sore throat, expectoration, runny nose, headache, nasal congestion, muscle aches, fatigue and other symptoms of influenza patients;
[0014] (4) Improper treatment can easily cause bronchial, pneumonia, tuberculosis and other symptoms, and a large amount of antibiotics are used

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine used for treating influenza, upper respiratory infection and viral pneumonia
  • Medicine used for treating influenza, upper respiratory infection and viral pneumonia
  • Medicine used for treating influenza, upper respiratory infection and viral pneumonia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1 A kind of medicine for treating influenza, upper respiratory tract infection, viral pneumonia

[0042] The drug is marine algae glycoprotein;

[0043] Said marine algae glycoprotein, in parts by weight, includes sugar 1%, protein 99%,

[0044] The molecular weight is 0.2kDa;

[0045] The marine algae are: cyanobacteria;

[0046] The sugar is a polysaccharide;

[0047] The polysaccharides include: galactose, sialic acid, mannose, arabinose, rhamnose;

[0048] The protein includes: glutamic acid, lysine, hydroxyproline, threonine, arginine;

Embodiment 2

[0049] Embodiment 2 A kind of medicine for treating influenza, upper respiratory tract infection, viral pneumonia

[0050] The drug is marine algae glycoprotein;

[0051] Said marine algae glycoprotein, in parts by weight, comprises sugar 6%, protein 85%,

[0052] The molecular weight is 16kDa;

[0053] The marine algae is: green algae;

[0054] The sugar is a polysaccharide;

[0055] The polysaccharides include: galactose, sialic acid, mannose, arabinose, rhamnose;

[0056] The protein includes: glutamic acid, lysine, hydroxyproline, threonine, arginine;

Embodiment 3

[0057] Embodiment 3 A kind of medicine for treating influenza, upper respiratory tract infection, viral pneumonia

[0058] The drug is marine algae glycoprotein;

[0059]Said marine algae glycoprotein, in parts by weight, comprises sugar 15%, protein 74%,

[0060] The molecular weight is 3kDa;

[0061] The marine algae are: cyanobacteria;

[0062] The sugar is a polysaccharide;

[0063] The polysaccharides include: galactose, sialic acid, mannose, arabinose, rhamnose;

[0064] The protein includes: glutamic acid, lysine, hydroxyproline, threonine, arginine;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Thicknessaaaaaaaaaa
Melting pointaaaaaaaaaa
Finenessaaaaaaaaaa
Login to View More

Abstract

The invention provides a medicine used for treating influenza, upper respiratory infection and viral pneumonia. The medicine is glycoprotein or a mixture of polysaccharide and protein or polypeptide or protein. The glycoprotein provided by the invention has a stabilization effect on body temperatures of endotoxin pyrogenic domestic rabbits, and has an obvious antipyretic effect; the medicine provided by the invention is used for treating the influenza, the upper respiratory infection and the viral pneumonia, and no symptoms of bronchitis, pneumonia and tuberculosis; the complication is 0; the toxin-free concentration of the medicine to Vero-E6 cells is 100 mu g / ml, and has an obvious inhibition effect on SARS viruses. The medicine provided by the invention has obvious pharmacologic actions on seven aspects of in-vitro virus resistance, in-vivo virus resistance, bacterium inhibition, inflammation resistance, antipyretic action, pain alleviation and immunologic function improvement; the medicine has the characteristics of safety, high efficiency and no side effect and has functions of preventing and treating respiratory system diseases, and broad-spectrum anti-virus, anti-inflammatory, anticoagulation, bacteria resisting, antipyretic and immunity adjusting functions.

Description

technical field [0001] The invention relates to a medicine for treating influenza, upper respiratory tract infection and viral pneumonia, and belongs to the technical field of medicine. Background technique [0002] Influenza (abbreviated as influenza) is an acute respiratory infection caused by influenza virus, and it is also a highly contagious and fast-spreading disease. It is mainly spread through droplets in the air, person-to-person contact or contact with contaminated items. The typical clinical symptoms are: sudden onset of high fever, general pain, significant fatigue and mild respiratory symptoms. Generally, autumn and winter are the high incidence period, and the complications and death caused by it are very serious. [0003] Early clinical symptoms of influenza include fever, cough, sore throat, body pain, headache, fever, etc. Some patients may also experience diarrhea or vomiting, muscle pain or fatigue, red eyes, etc. Sudden high fever, body temperature over...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/02A61K38/08A61P31/16A61P31/12A61P11/00A61P31/06A61K31/702A61K35/748A61K36/04A61K36/05A61K36/02A61K36/704A61K35/64A61K31/7012
CPCA61K31/7012A61K31/702A61K35/748A61K36/02A61K36/04A61K36/05A61K36/13A61K36/195A61K36/315A61K36/484A61K36/704A61K38/02A61K2300/00A61K38/08
Inventor 徐宝贞程龙程潜
Owner SHANDONG ZHONGHAI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com